19/01/2013 00:27:00

Johnson & Johnson in Talks for Hip Implant Settlement -Bloomberg

Related content

Johnson & Johnson (JNJ) is in talks to settle litigation over recalled hip implants, Bloomberg News reported Friday, citing five people familiar with the matter.

The settlement could total more than $2 billion if most plaintiffs accept the terms, Bloomberg reported.

According to the report, J&J has offered to pay more than $200,000 per case, while lawyers for plaintiffs have said the offer is too low.

Full story at http://www.bloomberg.com/news/2013-01-18/j-j-said-to-offer-implant-pact-that-may-reach-2-billion.html

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

January 18, 2013 19:27 ET (00:27 GMT)

Copyright (c) 2013 Dow Jones & Company, Inc.

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Regulatory news

Dimensional Fund Advisors Ltd. : Form 8.3 - John Wood Group Plc - Ordinary shares

21/09/2017 10:20:38
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

P. Schoenfeld Asset Management LLP : Form 8.3 - Booker Group plc

20/09/2017 15:00:11
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: P. Schoenfeld Asset Management LLP (b) Owner or..

Invesco Ltd. : Form 8.3 - Tesco Plc

20/09/2017 13:57:19
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Invesco Ltd. (b) Owner or control..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 Million of Common Stock
2
Student Transportation Inc. Reports Fourth Quarter & Fiscal Year 2017 Results
3
Telenor completes its sell-down in VEON
4
MotivAction Again Named as One of the Top 25 Meeting and Incentive Companies on MeetingsNet CMI 25 List
5
Penn Virginia to Participate in Johnson Rice Conference

Related stock quotes

Johnson & Johnson 133.22 0.0% Stock price unchanged

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 September 2017 13:23:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170921.1 - EUROWEB5 - 2017-09-21 14:23:28 - 2017-09-21 13:23:28 - 1000 - Website: OKAY